SCHEDULE OF SEGMENT REVENUE (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Segment Reporting [Line Items]
Revenues	$ 1,771	$ 1,778	$ 5,169	$ 3,307
Cost of Revenues:
Material and Labor	1,631	1,138	3,322	2,163
Other cost of revenues	302	327	849	539
Inventory write-off	612		1,085
Total Cost of Revenues	2,545	1,465	5,256	2,702
Research and development (R&D)
Share based compensation			4,323	5,940
Total Research and development	4,295	3,834	9,058	7,893
Selling and marketing (S&M)
Total Selling and marketing	5,221	4,172	10,401	6,922
General and administrative (G&A)
Total General and administrative	4,155	5,326	8,877	10,269
Financial Income (expenses), net;	121	(132)	410	162
Segment net loss	(14,324)	(13,151)	(28,013)	(24,317)
Location, Statement of Income, Balance [Axis]: us-gaap:GeneralAndAdministrativeExpense
Research and development (R&D)
Payroll and Benefits	1,365	1,729	3,172	3,309
Share based compensation	1,177	1,920	2,466	3,700
General and administrative (G&A)
Other G&A	1,613	1,677	3,239	3,260
Location, Statement of Income, Balance [Axis]: us-gaap:SellingAndMarketingExpense
Research and development (R&D)
Payroll and Benefits	3,932	2,779	7,795	4,757
Share based compensation	543	595	1,124	812
Selling and marketing (S&M)
Other S&M	746	798	1,482	1,353
Research and Development [Member]
Research and development (R&D)
Payroll and Benefits	1,282	1,120	2,882	1,974
Share based compensation	435	645	610	1,314
Clinical trials	972	1,125	2,473	2,287
Other R&D	$ 1,606	$ 944	$ 3,093	$ 2,318